Whole-genome long-read sequencing downsampling and its effect on variant-calling precision and recall
Genome Research · 2023-12 · 33 (12) · 2029-2040
DOI: 10.1101/gr.278070.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, online erschienen am 07.12.2023. Verfasst von William T Harvey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington 98195-5065, USA. Hauptthemen laut MEDLINE: Genomics, Nanopores. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHGRI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Advances in long-read sequencing (LRS) technologies continue to make whole-genome sequencing more complete, affordable, and accurate. LRS provides significant advantages over short-read sequencing approaches, including phased de novo genome assembly, access to previously excluded genomic regions, and discovery of more complex structural variants (SVs) associated with disease. Limitations remain with respect to cost, scalability, and platform-dependent read accuracy and the tradeoffs between sequence coverage and sensitivity of variant discovery are important experimental considerations for the application of LRS. We compare the genetic variant-calling precision and recall of Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio) HiFi platforms over a range of sequence coverages. For read-based applications, LRS sensitivity begins to plateau around 12-fold coverage with a majority of variants called with reasonable accuracy (F 1 score above 0.5), and both platforms perform well for SV detection. Genome assembly increases variant-calling precision and recall of SVs and indels in HiFi data sets with HiFi outperforming ONT in quality as measured by the F 1 score of assembly-based variant call sets. While both technologies continue to evolve, our work offers guidance to design cost-effective experimental strategies that do not compromise on discovering novel biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington 98195-5065, USA.
- Institute for Medical Biometry and Bioinformatics, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.
- Core Unit Bioinformatics, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.
- Center for Digital Medicine, Heinrich Heine University, 40225 Düsseldorf, Germany.
- The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.
- Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, Connecticut 06030-6403, USA.
Förderung
- NIGMS NIH HHS
- NHGRI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Harvey, W. T., Ebert, P., Ebler, J., Audano, P. A., Munson, K. M., Hoekzema, K., Porubsky, D., Beck, C. R., Marschall, T., Garimella, K., & Eichler, E. E. (2023). Whole-genome long-read sequencing downsampling and its effect on variant-calling precision and recall. Genome Research, 33(12), 2029-2040. https://doi.org/10.1101/gr.278070.123
Vancouver
Harvey WT, Ebert P, Ebler J, Audano PA, Munson KM, Hoekzema K, et al. Whole-genome long-read sequencing downsampling and its effect on variant-calling precision and recall. Genome Research. 2023;33(12):2029-2040. doi:10.1101/gr.278070.123
BibTeX
@article{Harvey2023,
author = {Harvey, William T and Ebert, Peter and Ebler, Jana and Audano, Peter A and Munson, Katherine M and Hoekzema, Kendra and Porubsky, David and Beck, Christine R and Marschall, Tobias and Garimella, Kiran and Eichler, Evan E},
title = {Whole-genome long-read sequencing downsampling and its effect on variant-calling precision and recall},
journal = {Genome Research},
year = {2023},
volume = {33},
number = {12},
pages = {2029--2040},
doi = {10.1101/gr.278070.123}
}
EUVIMED